Evidence map›Paper›PMID 40203087›Full record

ArticleScience advances2025

MprF from

Matthew T K Hankins, Matyas Parrag, Alisa A Garaeva, Jennifer C Earp, Markus A Seeger, Phillip J Stansfeld, Maike Bublitz

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Evolution of Lipids from Solvents to Substrates.Annual review of biophysics · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Opsins are Phospholipid Scramblases in All Domains of Life.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew T K HankinsDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.ORCID 0000-0003-2655-3247
Matyas ParragSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.ORCID 0009-0009-2992-8041
Alisa A GaraevaInstitute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Jennifer C EarpInstitute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.ORCID 0000-0003-3944-4533
Markus A SeegerInstitute of Medical Microbiology, University of Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.ORCID 0000-0003-1761-8571
Phillip J StansfeldSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0001-8800-7669
Maike BublitzDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.ORCID 0000-0003-3161-418X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multiple peptide resistance factor (MprF) is a bifunctional membrane protein found in many bacteria, including

Indexed as

Bacterial ProteinsPhospholipid Transfer ProteinsPseudomonas aeruginosaCryoelectron MicroscopyLiposomesMolecular Dynamics SimulationProtein ConformationSubstrate SpecificityBacterial ProteinsLiposomesPhospholipid Transfer Proteins

Identifiers

PMID40203087
PMCPMC11980842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.